Biblio Discovery — Demo Discovery Service

25 results for "Deflorian, Francesca"

Showing 1–20 · 0.63 seconds · RSS

  1. Journal Article Full text

    Comparison of three GPCR structural templates for modeling of the P2Y(12) nucleotide receptor

    Deflorian, Francesca; Jacobson, Kenneth A.

    J Comput Aided Mol Des · 2011 · English · PubMed Central

    The P2Y(12) receptor (P2Y(12)R) is an ADP-activated G protein-coupled receptor (GPCR) that is an important target for antithrombotic drugs. Three homology models of P2Y(12)R were compared, based on different GPCR structural templates: bovine rhodopsin (bRHO), human A(2A) adenosine receptor…

  2. Journal Article Full text

    Probing GPCR Structure: Adenosine and P2Y Nucleotide Receptors

    Jacobson, Kenneth A.; Costanzi, Stefano; Deflorian, Francesca

    Methods Enzymol · 2013 · English · PubMed Central

    The adenosine receptors (ARs) provide an example of how to accurately predict ligand recognition, even prior to the availability of a crystallographic structure. Homology modeling has been used to gain structural insight, in conjunction with site-directed mutagenesis and structure activity…

  3. Journal Article Full text

    Pharmacochemistry of the platelet purinergic receptors

    Jacobson, Kenneth A.; Deflorian, Francesca; Mishra, Shilpi et al.

    Purinergic Signal · 2011 · English · PubMed Central

    Platelets contain at least five purinergic G protein-coupled receptors, e.g., the pro-aggregatory P2Y(1) and P2Y(12) receptors, a P2Y(14) receptor (GPR105) of unknown function, and anti-aggregatory A(2A) and A(2B) adenosine receptor (ARs), in addition to the ligand-gated P2X1 ion channel. Probing…

  4. Journal Article Full text

    G protein-coupled adenosine (P1) and P2Y receptors: ligand design and receptor interactions

    Jacobson, Kenneth A.; Balasubramanian, Ramachandran; Deflorian, Francesca et al.

    Purinergic Signal · 2012 · English · PubMed Central

    The medicinal chemistry and pharmacology of the four subtypes of adenosine receptors (ARs) and the eight subtypes of P2Y receptors (P2YRs, activated by a range of purine and pyrimidine mono- and dinucleotides) has recently advanced significantly leading to selective ligands. X-ray crystallographic…

  5. Journal Article Full text

    Understanding Ligand Binding Selectivity in a Prototypical GPCR Family

    Mattedi, Giulio; Deflorian, Francesca; Mason, Jonathan S. et al.

    J Chem Inf Model · 2019 · English · PubMed Central

    [Image: see text] Adenosine receptors are involved in many pathological conditions and are thus promising drug targets. However, developing drugs that target this GPCR subfamily is a challenging task. A number of drug candidates fail due to lack of selectivity which results in unwanted side…

  6. Journal Article Full text

    Truncated (N)-Methanocarba Nucleosides as A(1) Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition Element

    Tosh, Dilip K.; Phan, Khai; Deflorian, Francesca et al.

    ACS Med Chem Lett · 2011 · English · PubMed Central

    [Image: see text] A(1) adenosine receptor (AR) agonists are neuroprotective, cardioprotective, and anxiolytic. (N)-Methanocarba adenine nucleosides designed to bind to human A(1)AR were truncated to eliminate 5′-CH(2)OH. This modification previously converted A(3)AR agonists into antagonists, but…

  7. Journal Article Full text

    Pyrazolo-triazolo-pyrimidines as adenosine receptor antagonists: A complete structure–activity profile

    Cacciari, Barbara; Bolcato, Chiara; Spalluto, Giampiero et al.

    Purinergic Signal · 2006 · English · PubMed Central

    In the last 5 years, many efforts have been conducted searching potent and selective human A(3) adenosine antagonists. In this field several different classes of compounds, possessing very good affinity (nM range) and with a broad range of selectivity, have been proposed. Recently, our group…

  8. Journal Article Full text

    High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks

    Mason, Jonathan S; Bortolato, Andrea; Weiss, Dahlia R et al.

    In Silico Pharmacol · 2013 · English · PubMed Central

    PURPOSE: G Protein-Coupled Receptors (GPCRs) are a large family of therapeutically important proteins and as diverse X-ray structures become available it is increasingly possible to leverage structural information for rational drug design. We present herein approaches that use explicit water…

  9. Journal Article Full text

    Demystifying the three dimensional structure of G protein-coupled receptors (GPCRs) with the aid of molecular modeling

    Moro, Stefano; Deflorian, Francesca; Spalluto, Giampiero et al.

    Chem Commun (Camb) · 2003 · English · PubMed Central

    We review our recent work on adenosine receptors, a family of GPCRs; focusing our attention on A(3) adenosine receptor, we have demonstrated that the reciprocal integration of different theoretical and experimental disciplines can be very useful for the successful protein-based design of new…

  10. Journal Article Full text

    Structural Basis of the Selectivity of the β(2)-Adrenergic Receptor for Fluorinated Catecholamines

    Pooput, Chaya; Rosemond, Erica; Karpiak, Joel et al.

    Bioorg Med Chem · 2009 · English · PubMed Central

    The important and diverse biological functions of adrenergic receptors, a subclass of G-protein coupled receptors (GPCRs), have made the search for compounds that selectively stimulate or inhibit the activity of different adrenergic receptor subtypes an important area of medicinal chemistry. We…

  11. Journal Article Full text

    Synthesis and Evaluation of 1,2,4-Triazolo[1,5-c]pyrimidine Derivatives as A(2A) Receptor-Selective Antagonists

    Shinkre, Bidhan A.; Kumar, T. Santhosh; Gao, Zhan-Guo et al.

    Bioorg Med Chem Lett · 2010 · English · PubMed Central

    Movement disorders such as Parkinson’s disease and Huntington’s disease are serious life-limiting and debilitating movement disorders. Their onset typically occurs from mid-life to late in life, and effective diagnostic techniques for detecting and following the disease course are lacking. Our goal…

  12. Journal Article Full text

    Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y(12) receptor-mediated platelet aggregation

    Högberg, Carl; Gidlöf, Olof; Deflorian, Francesca et al.

    Thromb Haemost · 2012 · English · PubMed Central

    Farnesyl pyrophosphate (FPP) is an intermediate in cholesterol biosynthesis, and it has also been reported to activate platelet LPA (lysophosphatidic acid) receptors. The aim of this study was to investigate the role of extracellular FPP in platelet aggregation. Human platelets were studied with…

  13. Journal Article Full text

    Click Modification in the N(6) Region of A(3) Adenosine Receptor-Selective Carbocyclic Nucleosides for Dendrimeric Tethering that Preserves Pharmacophore Recognition

    Tosh, Dilip K.; Phan, Khai; Deflorian, Francesca et al.

    Bioconjug Chem · 2012 · English · PubMed Central

    Adenosine derivatives were modified with alkynyl groups on N(6) substituents for linkage to carriers using Cu(I)-catalyzed click chemistry. Two parallel series, both containing a rigid North-methanocarba (bicyclo[3.1.0]hexane) ring system in place of ribose, behaved as A(3) adenosine receptor (AR)…

  14. Journal Article Full text

    Structural Sweet Spot for A(1) Adenosine Receptor Activation by Truncated (N)- Methanocarba Nucleosides: Receptor Docking and Potent Anticonvulsant Activity

    Tosh, Dilip K.; Paoletta, Silvia; Deflorian, Francesca et al.

    J Med Chem · 2012 · English · PubMed Central

    A(1) adenosine receptor (AR) agonists display antiischemic and antiepileptic neuroprotective activity, but peripheral cardiovascular side effects impeded their development. SAR study of N(6)-cycloalkylmethyl 4′-truncated (N)-methanocarba-adenosines identified 10 (MRS5474, N(6)-dicyclopropylmethyl…

  15. Journal Article Full text

    Impact of protein–ligand solvation and desolvation on transition state thermodynamic properties of adenosine A(2A) ligand binding kinetics

    Deganutti, Giuseppe; Zhukov, Andrei; Deflorian, Francesca et al.

    In Silico Pharmacol · 2017 · English · PubMed Central

    Ligand–protein binding kinetic rates are growing in importance as parameters to consider in drug discovery and lead optimization. In this study we analysed using surface plasmon resonance (SPR) the transition state (TS) properties of a set of six adenosine A(2A) receptor inhibitors, belonging to…

  16. Journal Article Full text

    Structure-Guided Design of A(3) Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions

    Tosh, Dilip K.; Deflorian, Francesca; Phan, Khai et al.

    J Med Chem · 2012 · English · PubMed Central

    (N)-Methanocarba adenosine 5′-methyluronamides containing known A(3) AR (adenosine receptor)-enhancing modifications, i.e. 2-(arylethynyl)adenine and N(6)-methyl or N(6)-(3-substituted-benzyl), were nanomolar full agonists of human (h) A(3)AR and highly selective (K(i) ~0.6 nM, N(6)-methyl…

  17. Journal Article Full text

    Evaluation of Molecular Modeling of Agonist Binding in Light of the Crystallographic Structure of an Agonist-Bound A(2A) Adenosine Receptor

    Deflorian, Francesca; Kumar, T. Santhosh; Phan, Khai et al.

    J Med Chem · 2011 · English · PubMed Central

    Molecular modeling of agonist binding to the human A(2A) adenosine receptor (AR) was assessed and extended in light of crystallographic structures. Heterocyclic adenine nitrogens of co-crystallized agonist overlayed corresponding positions of the heterocyclic base of a bound triazolotriazine…

  18. Journal Article Full text

    Optimization of Adenosine 5′-Carboxamide Derivatives as Adenosine Receptor Agonists Using Structure-Based Ligand Design and Fragment Screening

    Tosh, Dilip K.; Phan, Khai; Gao, Zhan-Guo et al.

    J Med Chem · 2012 · English · PubMed Central

    [Image: see text] Structures of G protein-coupled receptors (GPCRs) have a proven utility in the discovery of new antagonists and inverse agonists modulating signaling of this important family of clinical targets. Applicability of active-state GPCR structures to virtual screening and rational…

  19. Journal Article Full text

    Molecular Probes for the A(2A) Adenosine Receptor Based on a Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine Scaffold

    Kumar, T. Santhosh; Mishra, Shilpi; Deflorian, Francesca et al.

    Bioorg Med Chem Lett · 2010 · English · PubMed Central

    Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine derivatives such as SCH 442416 display high affinity and selectivity as antagonists for the human A(2A) adenosine receptor (AR). We extended ether-linked chain substituents at the p-position of the phenyl group using optimized O-alkylation. The…

  20. Journal Article Full text

    Alchemical Free Energy Calculations on Membrane-Associated Proteins

    Papadourakis, Michail; Sinenka, Hryhory; Matricon, Pierre et al.

    J Chem Theory Comput · 2023 · English · PubMed Central

    [Image: see text] Membrane proteins have diverse functions within cells and are well-established drug targets. The advances in membrane protein structural biology have revealed drug and lipid binding sites on membrane proteins, while computational methods such as molecular simulations can resolve…